May we go on with antibacterial prophylaxis for urinary tract infections?

Area of Science:

• Pediatric Nephrology
• Infectious Diseases
• Clinical Pharmacology

Background:

• Recurrent urinary tract infections (UTIs) with or without vesicoureteric reflux (VUR) are a primary indication for long-term antibacterial prophylaxis in pediatric patients.
• Current strategies for antibacterial prophylaxis in children are facing increased scrutiny and are no longer universally accepted.

Purpose of the Study:

• To evaluate the established efficacy of antibacterial prophylaxis in preventing recurrent UTIs and renal damage in at-risk infants and children.
• To highlight the need for prospective, randomized studies to define specific risk groups and prove the benefits of prophylaxis.

Main Methods:

• Review of current practices and existing data regarding antibacterial prophylaxis for recurrent UTIs in children.
• Identification of knowledge gaps concerning the proven benefits of prophylaxis in defined risk populations.

Main Results:

• The benefits of antibacterial prophylaxis in at-risk infants and children are not definitively supported by robust evidence.
• Prospective randomized studies are required to establish clear guidelines for prophylaxis use.

Conclusions:

• Antibacterial prophylaxis remains a common practice for preventing pyelonephritic damage and UTI recurrence in pediatric patients.
• Until conclusive evidence from further studies is available, prophylaxis will continue to be utilized for high-risk children.